£64m funding to back UK-wide plan to strengthen clinical research delivery
Patients across the UK will benefit from a super-charged clinical research system, backed by over £64m of dedicated investment, which will save lives across the country.
Following the bold vision Saving and Improving Lives: The Future of UK Clinical Research Delivery published in March, the UK government and devolved administrations today set out the first phase of activity to ensure research will have better health outcomes and allow more patients to be involved in, and benefit from, research of relevance to them.
The activity for the coming months will include the development and trial of new COVID-19 treatments and vaccines; making UK clinical research delivery easier through more rapid ethics reviews and faster approval processes; boosting clinical research capacity with more virtual and remote trials; increasing diversity and participation in research in communities traditionally under-served by research; and digitising the clinical research process to allow researchers to find patients, offer them places in trials, and monitor health outcomes.
Matt Hancock, Secretary of State for Health and Social Care, said: “Clinical research has been vital in our fight against COVID-19 and has saved thousands of lives. Working with the Scottish, Welsh and Northern Ireland governments, our ambitious UK-wide vision for the future of clinical research delivery is essential if we are to build on this exciting and life saving momentum. We are making this vision a reality by continuing to work closely with our partners across the UK, the NHS, regulators, industry and medical research sector. We will create a more innovative, resilient and patient-centred clinical research system.”